Submission to the Pharmaceutical Benefits Advisory Committee (PBAC) PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types

Autor: Tuffaha, Haitham W, Scuffham, Paul
Jazyk: angličtina
Rok vydání: 2018
DOI: 10.13140/rg.2.2.32950.60489
Databáze: OpenAIRE